APLENZIN ER 522 MG TABLET

bupropion hydrobromide
$212.4770per EA

Strength

522 mg/1

NDC

00187581230

Classification

Brand

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

9/17/2025

Active Ingredients

BUPROPION HYDROBROMIDE

Approval Type

New Drug (NDA)

FDA Application

NDA022108

On Market Since

4/23/2008

Pharmacological Classes

Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-0.5%

3Y

+20.1%

5Y

+37.7%

All

+295.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.